Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Claimed Company
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions read more
Very positive. Challenging but fair. Opportunity to grow.
What makes you most happy at work?
The opportunity to save and extend life.
What do you like best about the leadership team?
Communication. Confidence. Strategic. Flexible. Resilient.
What are some of the best things about your team?
The team works well together and are likable.
What is the best part about your compensation package?
Equity. Salary. Ignite Points. Car.
What is most positive about the culture and environment at your company?
Belief we are helping patients.
Other Employee Reviews for Karyopharm Therapeutics
×